Harvard & University of Massachusetts collaborators secure funding for developing Multi-functional

Updated: Feb 12, 2018

University of Massachusetts and Harvard faculty have secured funding for developing an ICT-powered global oncology platform which will be employed by the Global Health Catalyst to support  global health collaborations. The new platform will allow for multi-center clinical trials, telemedicine support and training of residents/students. Initial collaborations will include Institutions in a number of African countries where the GHC is currently supporting efforts to address the growing global burden of cancer: Nigeria, Tanzania, and Cameroon. The leading-edge platform will build on the NIH-funded QARC platform, adapting it for global health with anticipated participation of hundreds of diaspora oncology health professionals and subsequent scale-up to include other Low and Middle Income Countries.  The potential of the QARC platform for global health was elaborated during the 2017 GHC summit at Harvard Medical School, and the work has recently been published in the Red Journal

Read More

1 view0 comments

Recent Posts

See All
Join us
Connect with us


© 2014 - 2019 by Global Health Catalyst 

  • Black Facebook Icon
  • Black Twitter Icon
  • Website